H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on DENTSPLY SIRONA Inc (XRAY) today and set a price target of $40. The company’s shares closed yesterday at $36.98, close to its 52-week low of $33.93.
Selvaraju said:
“Our price target is derived from a comparable universe-based approach, which utilizes a price-to-earnings (P/E) multiple calculated from a group of peer companies in the medical and dental equipment arenas.”
According to TipRanks.com, Selvaraju is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -14.3% and a 21.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, Bausch Health Companies Inc, and Aerpio Pharmaceuticals Inc.
Currently, the analyst consensus on DENTSPLY SIRONA Inc is a Moderate Buy with an average price target of $42.67, a 15.4% upside from current levels. In a report issued on November 9, Barrington also maintained a Hold rating on the stock.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $68.98 and a one-year low of $33.93. Currently, DENTSPLY SIRONA Inc has an average volume of 2.9M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment and Consumables segments.
